Advancements in NGS Boosting the Gene Expression Analysis Market
Next-generation sequencing (NGS) is revolutionizing the Gene Expression Analysis Market. NGS allows rapid, large-scale profiling of the transcriptome, making gene expression studies more efficient and precise.
The adoption of NGS platforms in clinical research and drug discovery is expanding, with applications in oncology, immunology, and rare diseases. As costs decrease and accuracy improves, the market is poised for sustained growth globally.
Market Outlook: The market, worth USD 4.74 billion in 2024, is projected to reach USD 12.67 billion by 2034, growing at a 10.32% CAGR.
1 View